Search research articles
Contact Us
Filters
Showing results (151-160 of 202) with videos related to
Page
of 21
Sort By:
Molecular and Cellular Biology
|
June 1, 1988
Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector
R H Edwards, M J Selby, W C Mobley, et al.
Applied and Environmental Microbiology
|
November 1, 1996
Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii
A Sharma, H Nagata, N Hamada, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells
Kelsi M Sandoz, William G Valiant, Steven G Eriksen, et al.
Journal of Virology
|
August 22, 2008
Identification of a broad-spectrum arenavirus entry inhibitor
Ryan A Larson, Dongcheng Dai, Virginia T Hosack, et al.
Antiviral Research
|
May 16, 2008
Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model
Aysegul Nalca, Josh M Hatkin, Nicole L Garza, et al.
Cell
|
October 2, 1992
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
M K Spriggs, D E Hruby, C R Maliszewski, et al.
Infection and Immunity
|
March 24, 2005
Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine
Karen L Kotloff, Steven S Wasserman, Kevin F Jones, et al.
Journal of Computer-Aided Molecular Design
|
October 26, 2007
Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches
Vsevolod Katritch, Chelsea M Byrd, Vladimir Tseitin, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2006
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice
Debra C Quenelle, R M L Buller, Scott Parker, et al.
Infection and Immunity
|
December 19, 2000
Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion
T C Bolken, C A Franke, K F Jones, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 202) with videos related to
Sort By:
Page
of 21
Molecular and Cellular Biology
|
June 1, 1988
Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector
R H Edwards, M J Selby, W C Mobley, et al.
Applied and Environmental Microbiology
|
November 1, 1996
Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii
A Sharma, H Nagata, N Hamada, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells
Kelsi M Sandoz, William G Valiant, Steven G Eriksen, et al.
Journal of Virology
|
August 22, 2008
Identification of a broad-spectrum arenavirus entry inhibitor
Ryan A Larson, Dongcheng Dai, Virginia T Hosack, et al.
Antiviral Research
|
May 16, 2008
Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model
Aysegul Nalca, Josh M Hatkin, Nicole L Garza, et al.
Cell
|
October 2, 1992
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
M K Spriggs, D E Hruby, C R Maliszewski, et al.
Infection and Immunity
|
March 24, 2005
Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine
Karen L Kotloff, Steven S Wasserman, Kevin F Jones, et al.
Journal of Computer-Aided Molecular Design
|
October 26, 2007
Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches
Vsevolod Katritch, Chelsea M Byrd, Vladimir Tseitin, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2006
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice
Debra C Quenelle, R M L Buller, Scott Parker, et al.
Infection and Immunity
|
December 19, 2000
Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion
T C Bolken, C A Franke, K F Jones, et al.
Page
of 21